Activity Overview
This educational activity is an archive of the live conference held on July 24 and 25, 2026.
Target Audience
This educational activity is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer are also invited to attend.
Learning Objectives
Upon participation in this activity, learners will be better able to:
- Develop strategies to integrate targeted and cytotoxic agents for the management of patients with lung cancer
Sanja Dacic, MD, PhD
Professor of Pathology
Vice Chair and Director of Anatomic Pathology
Director, Thoracic Pathology
Department of Pathology
Yale School of Medicine
New Haven, CT
Rachel E. Sanborn, MD
Medical Director of Clinical Research
Medical Director, Thoracic Oncology Program
Medical Director, Phase I Clinical Trials Program
Earle A. Chiles Research Institute
Providence Cancer Institute
Portland, OR
Amy L. Cummings, MD, PhD
Thoracic Oncologist
David Geffen School of Medicine
University of California Los Angeles
Los Angeles, CA
Maximilian Diehn, MD, PhD, FASCO
Jack, Lulu, and Sam Willson Professor
Vice Chair of Research
Division Chief of Radiation and Cancer Biology
Department of Radiation Oncology
Stanford University School of Medicine
Stanford, CA
Marina Chiara Garassino, MD
Professor of Medicine
Director, Thoracic Oncology Program
The University of Chicago
Chicago, IL
Erin Gillaspie, MD, MPH, FACS
Associate Professor With Tenure
Chief of Thoracic Surgery
CHI Health Creighton University Medical Center
Omaha, NE
Lizza Hendriks, MD, PhD
Professor
Maastricht University
Pulmonologist
Maastricht UMC+ Comprehensive Cancer Center
Maastricht, Netherlands
Daniel Li, MD, PhD
Y3 Fellow, Hematology and Oncology
University of California, Los Angeles
Los Angeles, CA
Rachel E. Sanborn, MD
Medical Director of Clinical Research
Medical Director, Thoracic Oncology Program
Medical Director, Phase I Clinical Trials Program
Earle A. Chiles Research Institute
Providence Cancer Institute
Portland, OR
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here